Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Buellesfeld

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
JACC. Cardiovascular Interventions|May 25, 2013
Optimizing outcome of transcatheter aortic valve replacement: it is all about geometryLutz Buellesfeld
European Heart Journal|December 7, 2010
Transcatheter aortic valve implantation: the evidence is catching up with realityLutz Buellesfeld, Stephan Windecker
Expert Review of Medical Devices|February 7, 2007
BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery diseaseEberhard Grube, Lutz Buellesfeld
Herz|April 17, 2009
[Percutaneous aortic valve replacement - pro]Lutz Buellesfeld, Eberhard Grube
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Next generation of drug eluting stents'Sirolimus-analogues'Lutz Buellesfeld, Eberhard Grube
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Paclitaxel-eluting stents: current clinical experienceEberhard Grube, Lutz Buellesfeld
Reviews in Cardiovascular Medicine|June 9, 2004
Everolimus for stent-based intracoronary applicationsEberhard Grube, Lutz Buellesfeld
Herz|April 1, 2004
Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stentsEberhard Grube, Lutz Buellesfeld
Herz|April 1, 2004
ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?Lutz Buellesfeld, Eberhard Grube
JACC. Cardiovascular Interventions|May 26, 2012
A permanent solution for a temporary problem: transcatheter valve-in-valve implantation for failed transcatheter aortic valve replacementLutz Buellesfeld, Eberhard Grube
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
JACC. Cardiovascular Interventions|May 25, 2013
Optimizing outcome of transcatheter aortic valve replacement: it is all about geometryLutz Buellesfeld
European Heart Journal|December 7, 2010
Transcatheter aortic valve implantation: the evidence is catching up with realityLutz Buellesfeld, Stephan Windecker
Expert Review of Medical Devices|February 7, 2007
BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery diseaseEberhard Grube, Lutz Buellesfeld
Herz|April 17, 2009
[Percutaneous aortic valve replacement - pro]Lutz Buellesfeld, Eberhard Grube
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Next generation of drug eluting stents'Sirolimus-analogues'Lutz Buellesfeld, Eberhard Grube
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Paclitaxel-eluting stents: current clinical experienceEberhard Grube, Lutz Buellesfeld
Reviews in Cardiovascular Medicine|June 9, 2004
Everolimus for stent-based intracoronary applicationsEberhard Grube, Lutz Buellesfeld
Herz|April 1, 2004
Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stentsEberhard Grube, Lutz Buellesfeld
Herz|April 1, 2004
ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?Lutz Buellesfeld, Eberhard Grube
JACC. Cardiovascular Interventions|May 26, 2012
A permanent solution for a temporary problem: transcatheter valve-in-valve implantation for failed transcatheter aortic valve replacementLutz Buellesfeld, Eberhard Grube
Pageof 8